The Model Of A Well-Funded Biotech Startup

By J. David Owens

It can hardly be argued that COVID-19 changed the way life sciences business was conducted. A recent McKinsey & Company report indicated double-digit growth in 2019 and 2020 for the biotech industry, in areas including venture capital, partnerships, co-developments, and joint ventures. Initial public offerings grew by triple digits, and venture capital investment grew in biotech by 45%, to a global total of $36.6 billion in 2020.